Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

James Pritchett

Orthopaedic Surgery Seattle, WA Medical Doctor

NPI 1265421382 CMS profile 238264

601 Broadway Ste 600, Seattle, WA 98122

Open in the dashboard

General payments

$6,393,230

214 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, James Pritchett of Seattle, WA is reported in the CMS Open Payments database as having received $6,393,230 across 214 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $312 4
2024 General $502 27
2023 General $3,519,975 32
2022 General $860,614 47
2021 General $809,757 36
2020 General $577,572 30
2019 General $624,499 38

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • James Pritchett
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to James Pritchett were reported at $312. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year James Pritchett Orthopaedic Surgery median Middle half National median
2019 $624,499 $644 $140–$2,844 $163
2020 $577,572 $312 $75–$1,860 $114
2021 $809,757 $520 $117–$2,495 $132
2022 $860,614 $598 $128–$2,731 $149
2023 $3,519,975 $461 $128–$2,264 $160
2024 $502 $497 $134–$2,475 $164
2025 $312 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $6,362,796 30 payments
  2. Smith+Nephew, Inc. $16,071 10 payments
  3. MicroPort Orthopedics Inc $10,689 15 payments
  4. Medacta USA, Inc. $1,815 3 payments
  5. Djo, LLC $784 144 payments
  6. Stryker Corporation $524 5 payments
  7. Exactech, Inc. $191 1 payment
  8. Orthalign Inc $150 2 payments
  9. BioPro, Inc. $134 1 payment
  10. Orthofix Medical, Inc. $47 2 payments
  11. Other $28 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $6,362,476 27 payments
  2. Consulting Fee $16,031 5 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,784 147 payments
  4. Travel and Lodging $2,948 10 payments
  5. Food and Beverage $1,991 25 payments
Products named General payments · program years 2019–2025
  1. Persona Knees $4,369,204 12 payments
  2. Persona Knees $1,183,806 8 payments
  3. Persona Knees $732,784 4 payments
  4. Persona Revision $76,682 3 payments
  5. MPO Medial Pivot Knee $10,689 15 payments
  6. AMISTEM $1,800 2 payments
  7. Journey II XR $1,402 2 payments
  8. Journey II $431 1 payment
  9. PROCARE $392 72 payments
  10. MAKO $368 3 payments
  11. Other $1,493 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

35

Median for Orthopedic Surgery: 203

Drug cost

$1,173

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Hyclate Generic 14 $1,097
Oxycodone Hcl Generic 21 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$115,170

Medicare's payments for the services billed

Medicare patients

227

Average age 73

Services billed

673

132 women, 95 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 48%
Depression 16%
Atrial fibrillation 14%
Ischemic heart disease 13%
Cancer 13%
Diabetes 11%
Osteoporosis 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

214 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Washington

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record